The Technical AnalystExchange: SHZ Sector: Healthcare Industry: Drug Manufacturers—Specialty & Generic
Tonghua Golden-Horse Price, Forecast, Insider, Ratings, Fundamentals & Signals
2.56% CNY17.60
America/New_York / 5 mai 2024 @ 23:45
| FUNDAMENTALS | |
|---|---|
| MarketCap: | 17 010 mill |
| EPS: | 0.0500 |
| P/E: | 352.00 |
| Earnings Date: | Jun 20, 2024 |
| SharesOutstanding: | 966.50 mill |
| Avg Daily Volume: | 40.42 mill |
| RATING 2024-04-30 |
|---|
| A |
| Buy |
| RATINGS | ||
|---|---|---|
| Rating CashFlow: | Neutral | |
| Return On Equity: | Sell | |
| Return On Asset: | Neutral | |
| DE: | Strong Buy | |
| P/E: | Strong Buy | |
| Price To Book: | Strong Buy |
| QUARTER GROWTHS | ||||||
|---|---|---|---|---|---|---|
| 4/22 | 1/23 | 2/23 | 3/23 | 4/23 | 1/24 | |
| Revenue | ||||||
| Gr.Profit | ||||||
| Ebit | ||||||
| Asset | ||||||
| Debt |
| PE RATIO: COMPANY / SECTOR |
|---|
| 9.82x |
| Company: PE 352.00 | sector: PE 35.84 |
| PE RATIO: COMPANY / INDUSTRY |
|---|
| 7.73x |
| Company: PE 352.00 | industry: PE 45.57 |
| DISCOUNTED CASH FLOW VALUE |
|---|
|
CNY3.03 (-82.77%) CNY-14.57 |
| Date: 2024-05-05 |
| Expected Trading Range (DAY) |
|---|
|
CNY 16.69 - 18.51 ( +/- 5.17%) |
| ATR Model: 14 days |
Live Trading Signals (every 1 min)
10.00
Buy
Last version updated: Fri April 15th, 2022
| Indicator Signals | |
|---|---|
| RSI 21 | |
| SMA | |
| Trend | |
| Trend 2 | |
| Trend 3 | |
| MACD |
| Volume Signals | |
|---|---|
| Price | CNY17.60 (2.56% ) |
| Volume | 14.51 mill |
| Avg. Vol. | 40.42 mill |
| % of Avg. Vol | 35.89 % |
| Signal 1: | |
| Signal 2: |
Today
Last 12 Months
RSI
Last 10 Buy & Sell Signals For 000766.SZ
0 Signals | Accuracy: 0.00% | Accuracy Buy: 0.00% | Accuracy Sell: 0.00%
Avg return buy: 0.00 % | Avg return sell: 0.00 %
$1 invested is now $1.00 or 0.00% since Coming Soon
| Date | Signal | @ | Closed | % |
|---|
000766.SZ
Tonghua Golden-Horse Pharmaceutical Industry Co., Ltd. engages in the research, development, manufacture, and sale of pharmaceutical products in China. Its products primarily focus on the rheumatism, digestion, cancer, and gynecology fields. The company offers traditional Chinese medicines, such as gynecological, rheumatic and bone pain, urology, detoxification, cardio-cerebral, digestive, respiratory, diabetes, and pediatric medication products, as well as anti-tumor drugs, prescription and OTC drugs, and Western medicines. The company offers its products in the form of capsules, tablets, injections, liquids, etc. Tonghua Golden-Horse Pharmaceutical Industry Co., Ltd. was founded in 1990 and is based in Tonghua, China.